So they wouldn’t sign a drug manufacturing contract if a deal wasn’t close. I doubt the manufacturer would either. It’s obvious a partnership or buyout are the only options. Most likely waiting for P. The buyout range or partnership terms must be pretty sweat depending on results; otherwise Leo would have signed a B deal by now, which is very clear that he can based on results of B trial. Given that P results can hit any day, I’m adding at extremely cheap prices. A deal will mean IPIX gets repriced all depends on the terms on how high it will go.